(331631, 'HP:0000603', 'Central scotoma', 'MP:0003011', 'delayed dark adaptation', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(331632, 'HP:0000603', 'Central scotoma', 'MP:0013468', 'chromodacryorrhea', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(331633, 'HP:0000603', 'Central scotoma', 'MP:0004021', 'abnormal rod electrophysiology', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(331634, 'HP:0000603', 'Central scotoma', 'MP:0013145', 'eye discharge', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(331635, 'HP:0000603', 'Central scotoma', 'MP:0006150', 'double vision', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(331636, 'HP:0000603', 'Central scotoma', 'MP:0010748', 'abnormal visual evoked potential', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(331637, 'HP:0000603', 'Central scotoma', 'MP:0012035', 'abnormal b-wave shape', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(331638, 'HP:0000603', 'Central scotoma', 'MP:0006190', 'retina ischemia', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(331639, 'HP:0000603', 'Central scotoma', 'MP:0020860', 'abnormal cornea physiology', 0.42857142857142855, 8.795504987450572, 1.9415205735399295, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(331640, 'HP:0000603', 'Central scotoma', 'MP:0020974', 'abnormal FO-wave shape', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(331641, 'HP:0000603', 'Central scotoma', 'MP:0020220', 'decreased tear production', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(331642, 'HP:0000603', 'Central scotoma', 'MP:0020425', 'abnormal retinal bipolar cell electrophysiology', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(331643, 'HP:0000603', 'Central scotoma', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(331644, 'HP:0000603', 'Central scotoma', 'MP:0002090', 'abnormal vision', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(331645, 'HP:0000603', 'Central scotoma', 'MP:0005551', 'abnormal eye electrophysiology', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(331646, 'HP:0000603', 'Central scotoma', 'MP:0011831', 'abnormal visual contrast sensitivity', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(331647, 'HP:0000603', 'Central scotoma', 'MP:0012033', 'abnormal ERG implicit time', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(331648, 'HP:0000603', 'Central scotoma', 'MP:0020439', 'absent b-wave', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(331649, 'HP:0000603', 'Central scotoma', 'MP:0012040', 'abnormal c-wave shape', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(331650, 'HP:0000603', 'Central scotoma', 'MP:0003096', 'increased corneal light-scattering', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(331651, 'HP:0000603', 'Central scotoma', 'MP:0014132', 'abnormal tear film physiology', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(331652, 'HP:0000603', 'Central scotoma', 'MP:0020218', 'abnormal tear production', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(331653, 'HP:0000603', 'Central scotoma', 'MP:0011832', 'abnormal visual acuity', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(331654, 'HP:0000603', 'Central scotoma', 'MP:0012034', 'abnormal a-wave shape', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(331655, 'HP:0000603', 'Central scotoma', 'MP:0006153', 'hypermetropia', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(331656, 'HP:0000603', 'Central scotoma', 'MP:0008145', 'hemeralopia', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(331657, 'HP:0011333', 'Asymmetric crying face', 'MP:0006209', 'calcified intraocular region', 0.4222222222222222, 5.913369942082322, 1.5801127167920936, 'UPHENO:0087472', 'abnormal face morphology'),
(331658, 'HP:0011333', 'Asymmetric crying face', 'MP:0030043', 'small forehead', 0.40425531914893614, 5.913369942082322, 1.5461278256283388, 'UPHENO:0087472', 'abnormal face morphology'),
(331659, 'HP:0011333', 'Asymmetric crying face', 'MP:0002697', 'abnormal eye size', 0.4222222222222222, 5.913369942082322, 1.5801127167920936, 'UPHENO:0087472', 'abnormal face morphology'),
(331660, 'HP:0011333', 'Asymmetric crying face', 'MP:0003743', 'abnormal facial morphology', 0.43243243243243246, 5.913369942082322, 1.5991037952326579, 'UPHENO:0087472', 'abnormal face morphology'),
(331661, 'HP:0011333', 'Asymmetric crying face', 'MP:0030067', 'narrow face', 0.4166666666666667, 11.592196926445306, 2.197744765136649, 'UPHENO:0020809', 'abnormal face morphology'),
(331662, 'HP:0011333', 'Asymmetric crying face', 'MP:0008798', 'lateral facial cleft', 0.4166666666666667, 11.592196926445306, 2.197744765136649, 'UPHENO:0020809', 'abnormal face morphology'),
(331663, 'HP:0011333', 'Asymmetric crying face', 'MP:0011496', 'abnormal head size', 0.4358974358974359, 4.6730878730104815, 1.4272305425433802, 'UPHENO:0087907', 'abnormal head morphology'),
(331664, 'HP:0011333', 'Asymmetric crying face', 'MP:0012546', 'triangular face', 0.40816326530612246, 11.592196926445306, 2.1752031973058314, 'UPHENO:0020809', 'abnormal face morphology'),
(331665, 'HP:0011333', 'Asymmetric crying face', 'MP:0030041', 'abnormal forehead size', 0.4418604651162791, 5.913369942082322, 1.6164418928662792, 'UPHENO:0087472', 'abnormal face morphology'),
(331666, 'HP:0011333', 'Asymmetric crying face', 'MP:0008799', 'oblique facial cleft', 0.4166666666666667, 11.592196926445306, 2.197744765136649, 'UPHENO:0020809', 'abnormal face morphology'),
(331667, 'HP:0011333', 'Asymmetric crying face', 'MP:0030070', 'long face', 0.40816326530612246, 11.592196926445306, 2.1752031973058314, 'UPHENO:0020809', 'abnormal face morphology'),
(331668, 'HP:0011333', 'Asymmetric crying face', 'MP:0030065', 'face hypoplasia', 0.40816326530612246, 11.592196926445306, 2.1752031973058314, 'UPHENO:0020809', 'abnormal face morphology'),
(331669, 'HP:0011333', 'Asymmetric crying face', 'MP:0008862', 'asymmetric snout', 0.4883720930232558, 12.126020578174659, 2.433518039753605, 'UPHENO:0084729', 'abnormal asymmetry of anatomical entity'),
(331670, 'HP:0011333', 'Asymmetric crying face', 'MP:0030069', 'broad face', 0.4166666666666667, 11.592196926445306, 2.197744765136649, 'UPHENO:0020809', 'abnormal face morphology'),
(331671, 'HP:0011333', 'Asymmetric crying face', 'MP:0030045', 'abnormal forehead shape', 0.41304347826086957, 5.913369942082322, 1.5628432068256108, 'UPHENO:0087472', 'abnormal face morphology'),
(331672, 'HP:0011333', 'Asymmetric crying face', 'MP:0030063', 'abnormal face size', 0.5, 11.592196926445306, 2.407508767008472, 'UPHENO:0020809', 'abnormal face morphology'),
(331673, 'HP:0011333', 'Asymmetric crying face', 'MP:0031503', 'abnormal mouth size', 0.40425531914893614, 5.913369942082322, 1.5461278256283388, 'UPHENO:0087472', 'abnormal face morphology'),
(331674, 'HP:0011333', 'Asymmetric crying face', 'MP:0030313', 'abnormal face development', 0.41025641025641024, 5.913369942082322, 1.557561531675988, 'UPHENO:0087472', 'abnormal face morphology'),
(331675, 'HP:0011333', 'Asymmetric crying face', 'MP:0030095', 'abnormal midface morphology', 0.41025641025641024, 5.913369942082322, 1.557561531675988, 'UPHENO:0087472', 'abnormal face morphology'),
(331676, 'HP:0011333', 'Asymmetric crying face', 'MP:0008797', 'facial cleft', 0.425531914893617, 11.592196926445306, 2.2210019711684574, 'UPHENO:0020809', 'abnormal face morphology'),
(331677, 'HP:0011333', 'Asymmetric crying face', 'MP:0006164', 'ectropion', 0.43478260869565216, 7.255471829629861, 1.7761061256029402, 'UPHENO:0080369', 'abnormal spatial pattern of anatomical entity'),
(331678, 'HP:0011333', 'Asymmetric crying face', 'MP:0030071', 'abnormal face shape', 0.46511627906976744, 11.592196926445306, 2.322007644404349, 'UPHENO:0020809', 'abnormal face morphology'),
(331679, 'HP:0011333', 'Asymmetric crying face', 'MP:0008863', 'craniofacial asymmetry', 0.48717948717948717, 12.126020578174659, 2.4305448950395956, 'UPHENO:0084729', 'abnormal asymmetry of anatomical entity'),
(331680, 'HP:0011333', 'Asymmetric crying face', 'MP:0030190', 'small snout', 0.41304347826086957, 5.913369942082322, 1.5628432068256108, 'UPHENO:0087472', 'abnormal face morphology'),
(331681, 'HP:0011333', 'Asymmetric crying face', 'MP:0030073', 'square face', 0.4166666666666667, 11.592196926445306, 2.197744765136649, 'UPHENO:0020809', 'abnormal face morphology'),
(331682, 'HP:0011333', 'Asymmetric crying face', 'MP:0030068', 'large face', 0.45454545454545453, 11.592196926445306, 2.295469542623361, 'UPHENO:0020809', 'abnormal face morphology'),
(331683, 'HP:0011333', 'Asymmetric crying face', 'MP:0006225', 'ocular rupture', 0.4222222222222222, 5.913369942082322, 1.5801127167920936, 'UPHENO:0087472', 'abnormal face morphology'),
(331684, 'HP:0011333', 'Asymmetric crying face', 'MP:0011495', 'abnormal head shape', 0.40476190476190477, 4.6730878730104815, 1.3753137636915733, 'UPHENO:0087907', 'abnormal head morphology'),
(331685, 'HP:0011333', 'Asymmetric crying face', 'MP:0003671', 'abnormal eyelid aperture', 0.40425531914893614, 5.913369942082322, 1.5461278256283388, 'UPHENO:0087472', 'abnormal face morphology'),
(331686, 'HP:0011333', 'Asymmetric crying face', 'MP:0030074', 'coarse facial features', 0.45454545454545453, 11.592196926445306, 2.295469542623361, 'UPHENO:0020809', 'abnormal face morphology'),
(331687, 'HP:0011333', 'Asymmetric crying face', 'MP:0030064', 'small face', 0.45454545454545453, 11.592196926445306, 2.295469542623361, 'UPHENO:0020809', 'abnormal face morphology'),
(331688, 'HP:0011333', 'Asymmetric crying face', 'MP:0030042', 'large forehead', 0.40425531914893614, 5.913369942082322, 1.5461278256283388, 'UPHENO:0087472', 'abnormal face morphology'),
(331689, 'HP:0011333', 'Asymmetric crying face', 'MP:0030066', 'short face', 0.40816326530612246, 11.592196926445306, 2.1752031973058314, 'UPHENO:0020809', 'abnormal face morphology'),
(331690, 'HP:0011333', 'Asymmetric crying face', 'MP:0001788', 'periorbital edema', 0.40425531914893614, 5.913369942082322, 1.5461278256283388, 'UPHENO:0087472', 'abnormal face morphology'),
(331691, 'HP:0011333', 'Asymmetric crying face', 'MP:0030099', 'facial asymmetry', 0.46938775510204084, 15.022184767190119, 2.6554151435508992, 'UPHENO:0084734', 'abnormal asymmetry of face'),
(331692, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331693, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331694, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331695, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331696, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011994', 'increased nerve conduction velocity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331697, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003220', 'decreased spike-wave discharge type II', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331698, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003762', 'abnormal immune organ physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331699, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331700, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011001', 'absence of AMPA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331701, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331702, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002499', 'chronic inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331703, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011270', 'decreased excitatory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331704, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331705, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331706, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0000920', 'abnormal myelination', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331707, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331708, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003009', 'abnormal cytokine secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331709, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331710, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331711, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331712, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0005447', 'abnormal synaptic norepinephrine release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331713, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331714, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003476', 'decreased summary potential intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331715, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331716, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331717, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331718, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331719, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331720, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003487', 'increased channel response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331721, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331722, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331723, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331724, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331725, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331726, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004494', 'abnormal synaptic glutamate release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331727, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0005402', 'abnormal action potential', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331728, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003467', 'abnormal single cell response intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331729, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331730, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331731, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331732, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003469', 'decreased single cell response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331733, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331734, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331735, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331736, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331737, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331738, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331739, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003474', 'abnormal summary potential intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331740, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0014253', 'decreased paired-pulse ratio', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331741, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331742, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0009475', 'abnormal nicotine-mediated receptor currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331743, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0014254', 'increased paired-pulse ratio', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331744, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331745, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331746, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003465', 'increased single cell response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331747, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331748, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331749, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331750, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331751, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003088', 'abnormal prepulse inhibition', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331752, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331753, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331754, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331755, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331756, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003218', 'decreased spike-wave discharge type I', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331757, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331758, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331759, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331760, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0014256', 'decreased paired-pulse inhibition', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331761, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003488', 'decreased channel response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331762, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011269', 'increased excitatory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331763, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331764, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331765, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331766, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331767, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331768, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004768', 'abnormal axonal transport', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331769, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331770, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001835', 'abnormal antigen presentation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331771, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010050', 'hypermyelination', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331772, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331773, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003481', 'decreased nerve fiber response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331774, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0020002', 'increased response to antigen', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331775, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331776, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331777, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0009142', 'decreased prepulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331778, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331779, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331780, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004835', 'abnormal miniature endplate potential', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331781, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331782, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331783, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331784, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331785, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003997', 'tonic-clonic seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331786, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004859', 'abnormal synaptic plasticity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331787, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0005645', 'abnormal hypothalamus physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331788, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0008568', 'abnormal interleukin secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331789, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331790, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331791, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331792, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331793, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002635', 'reduced sensorimotor gating', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331794, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331795, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331796, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331797, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0008921', 'increased neurotransmitter release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331798, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331799, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331800, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331801, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001912', 'increased cerebrospinal fluid production', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331802, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331803, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331804, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331805, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331806, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331807, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331808, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331809, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331810, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331811, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004752', 'decreased length of allograft survival', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331812, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001499', 'abnormal kindling response', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331813, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331814, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331815, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331816, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331817, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011397', 'endoneurial edema', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331818, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331819, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331820, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0013596', 'abnormal vomeronasal organ physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331821, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331822, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331823, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331824, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001915', 'intracranial hemorrhage', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331825, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0014179', 'abnormal blood-retina barrier function', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331826, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331827, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331828, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331829, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331830, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331831, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331832, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331833, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331834, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0005025', 'abnormal response to infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331835, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0013570', 'abnormal neuroendocrine gland physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331836, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331837, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331838, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331839, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331840, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331841, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331842, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331843, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002578', 'impaired ability to fire action potentials', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331844, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331845, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002923', 'increased post-tetanic potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331846, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003996', 'clonic seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331847, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0031090', 'ageusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331848, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331849, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001800', 'abnormal humoral immune response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331850, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010653', 'abnormal Wallerian degeneration', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331851, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010654', 'slow Wallerian degeneration', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331852, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331853, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331854, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331855, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331856, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331857, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331858, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002471', 'abnormal complement pathway', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331859, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331860, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001846', 'increased inflammatory response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331861, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331862, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331863, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331864, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331865, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331866, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331867, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331868, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331869, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002945', 'abnormal inhibitory postsynaptic currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331870, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331871, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331872, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331873, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331874, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331875, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331876, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0020424', 'increased kindling response', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331877, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331878, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0009358', 'environmentally induced seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331879, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004753', 'abnormal miniature excitatory postsynaptic currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331880, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331881, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003483', 'decreased nerve fiber response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331882, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0005004', 'abnormal lymphocyte anergy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331883, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0013806', 'encephalopathy', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331884, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010746', 'abnormal pre-Botzinger complex physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331885, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331886, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331887, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0014178', 'increased brain apoptosis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331888, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0005403', 'abnormal nerve conduction', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331889, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331890, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003990', 'decreased neurotransmitter release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331891, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331892, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331893, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331894, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331895, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331896, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331897, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001901', 'absence of NMDA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331898, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003485', 'abnormal channel response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331899, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003777', 'lip inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331900, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331901, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331902, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331903, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010149', 'abnormal synaptic dopamine release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331904, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003464', 'abnormal single cell response threshold', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331905, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331906, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331907, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331908, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002922', 'decreased post-tetanic potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331909, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331910, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0012011', 'febrile seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331911, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331912, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002500', 'granulomatous inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331913, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331914, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001898', 'abnormal long-term depression', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331915, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001916', 'intracerebral hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331916, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0012504', 'increased forebrain apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331917, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0014252', 'abnormal paired-pulse ratio', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331918, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331919, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331920, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331921, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331922, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0005005', 'abnormal self tolerance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331923, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331924, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002911', 'abnormal inhibitory postsynaptic potential', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331925, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331926, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331927, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0005671', 'abnormal response to transplant', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331928, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0030132', 'periodontium inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331929, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011274', 'short excitatory postsynaptic current decay time', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331930, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331931, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331932, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003234', 'enhanced NMDA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331933, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331934, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003219', 'increased spike-wave discharge type II', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331935, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0020000', 'abnormal response to antigen', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331936, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331937, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003477', 'abnormal nerve fiber response', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331938, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002914', 'abnormal endplate potential', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331939, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331940, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331941, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331942, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331943, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331944, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331945, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331946, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331947, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331948, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331949, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002887', 'decreased susceptibility to pharmacologically induced seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331950, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331951, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331952, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331953, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331954, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003470', 'abnormal summary potential', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331955, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331956, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331957, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331958, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331959, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0005001', 'abnormal clonal deletion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331960, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331961, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331962, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331963, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331964, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331965, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331966, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331967, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331968, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331969, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331970, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331971, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331972, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331973, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331974, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0008744', 'abnormal B cell anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331975, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002916', 'increased synaptic depression', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331976, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0005043', 'defective assembly of class II molecules', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331977, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331978, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331979, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0005000', 'abnormal immune tolerance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331980, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003635', 'abnormal synaptic transmission', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331981, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331982, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002420', 'abnormal adaptive immunity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331983, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001473', 'reduced long-term potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331984, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002906', 'increased susceptibility to pharmacologically induced seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331985, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331986, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331987, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003471', 'abnormal summary potential threshold', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331988, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331989, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0021016', 'decreased tau protein phosphorylation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331990, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331991, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0031110', 'meningitis', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331992, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331993, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331994, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331995, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0000947', 'convulsive seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(331996, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331997, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331998, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(331999, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0006080', 'brain ischemia', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332000, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332001, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332002, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332003, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002195', 'psychomotor seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332004, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332005, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332006, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332007, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0006058', 'decreased cerebral infarct size', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332008, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0020155', 'enhanced humoral immune response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332009, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332010, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332011, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332012, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332013, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332014, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001793', 'abnormal susceptibility to infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332015, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332016, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332017, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332018, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332019, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332020, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332021, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332022, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332023, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332024, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332025, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332026, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332027, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0008840', 'abnormal spike wave discharge', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332028, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332029, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332030, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0000921', 'demyelination', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332031, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332032, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001847', 'brain inflammation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332033, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332034, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332035, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332036, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332037, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332038, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332039, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332040, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332041, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002498', 'abnormal acute inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332042, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003480', 'increased nerve fiber response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332043, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003468', 'increased single cell response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332044, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001837', 'defective assembly of class I molecules', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332045, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0012261', 'increased hindbrain apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332046, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332047, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0030153', 'dental pulp inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332048, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0021001', 'impaired neuron physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332049, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0012502', 'decreased hindbrain apoptosis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332050, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332051, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332052, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332053, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332054, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332055, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001475', 'reduced long-term depression', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332056, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332057, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332058, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0021010', 'impaired synaptic physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332059, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332060, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332061, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0031333', 'decreased inhibitory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332062, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332063, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332064, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003482', 'increased nerve fiber response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332065, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332066, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332067, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332068, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332069, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332070, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332071, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0014255', 'increased paired-pulse inhibition', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332072, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332073, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0006060', 'increased cerebral infarct size', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332074, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332075, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332076, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001876', 'decreased inflammatory response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332077, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332078, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332079, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002915', 'abnormal synaptic depression', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332080, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003466', 'decreased single cell response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332081, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332082, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332083, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0009967', 'abnormal neuron proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332084, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332085, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001845', 'abnormal inflammatory response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332086, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0005333', 'decreased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332087, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001790', 'abnormal immune system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332088, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332089, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332090, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332091, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002723', 'abnormal immune serum protein physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332092, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332093, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332094, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004994', 'abnormal brain wave pattern', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332095, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332096, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332097, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011267', 'abnormal excitatory postsynaptic current amplitude', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332098, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332099, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002193', 'minimal clonic seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332100, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332101, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332102, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332103, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332104, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011399', 'increased endoneurial fluid pressure', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332105, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0013182', 'increased spinal cord apoptosis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332106, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003216', 'absence seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332107, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332108, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332109, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332110, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003486', 'abnormal channel response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332111, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332112, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332113, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332114, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332115, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002920', 'decreased paired-pulse facilitation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332116, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332117, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332118, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003217', 'increased spike-wave discharge type I', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332119, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332120, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332121, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332122, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0031109', 'subarachnoid hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332123, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332124, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332125, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332126, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332127, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332128, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003489', 'increased channel response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332129, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332130, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332131, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002917', 'decreased synaptic depression', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332132, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332133, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004495', 'decreased synaptic glutamate release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332134, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332135, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332136, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332137, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332138, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332139, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332140, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002421', 'abnormal cell-mediated immunity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332141, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332142, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332143, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332144, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002419', 'abnormal innate immunity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332145, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003475', 'increased summary potential intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332146, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332147, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332148, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332149, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332150, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332151, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332152, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332153, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011003', 'reduced AMPA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332154, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332155, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0000948', 'nonconvulsive seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332156, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004751', 'increased length of allograft survival', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332157, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332158, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332159, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332160, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332161, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332162, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332163, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332164, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0012565', 'perivasculitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332165, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332166, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0008722', 'abnormal chemokine secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332167, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002826', 'tonic seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332168, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003463', 'abnormal single cell response', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332169, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332170, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011273', 'prolonged excitatory postsynaptic current decay time', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332171, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332172, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332173, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332174, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003633', 'abnormal nervous system physiology', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332175, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332176, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003880', 'abnormal central pattern generator function', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332177, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332178, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332179, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332180, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0012503', 'increased midbrain apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332181, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332182, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332183, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332184, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332185, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332186, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0020001', 'decreased response to antigen', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332187, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332188, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0021009', 'abnormal synaptic physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332189, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010368', 'abnormal lymphatic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332190, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0021027', 'abnormal cerebrospinal fluid amyloid beta 40 isoform level', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332191, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0021015', 'increased tau protein phosphorylation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332192, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332193, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011002', 'enhanced AMPA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332194, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332195, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332196, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003202', 'abnormal neuron apoptosis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332197, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332198, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0008555', 'abnormal interferon secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332199, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332200, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332201, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332202, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004811', 'abnormal neuron physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332203, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332204, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332205, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332206, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003490', 'decreased channel response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332207, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332208, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001500', 'decreased kindling response', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332209, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0005044', 'sepsis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332210, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332211, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0031334', 'increased inhibitory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332212, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0012006', 'abnormal hippocampus physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332213, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002888', 'abnormal NMDA-mediated synaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332214, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332215, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0006053', 'hypothalamus hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332216, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332217, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332218, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332219, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332220, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002207', 'abnormal long-term potentiation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332221, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0031332', 'abnormal inhibitory postsynaptic current amplitude', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332222, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332223, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0031117', 'subdural hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332224, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011268', 'biphasic excitatory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332225, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004836', 'abnormal synaptic acetylcholine release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332226, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332227, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0008814', 'decreased nerve conduction velocity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332228, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332229, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332230, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0009141', 'increased prepulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332231, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332232, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332233, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332234, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332235, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003472', 'increased summary potential threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332236, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332237, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332238, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0006054', 'spinal hemorrhage', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332239, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332240, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332241, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332242, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332243, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0006052', 'cerebellum hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332244, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332245, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0021082', 'abnormal cerebrospinal fluid amyloid beta 42 isoform level', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332246, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011271', 'prolonged excitatory postsynaptic current rise time', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332247, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002064', 'seizures', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332248, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332249, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001752', 'abnormal hypothalamus secretion', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332250, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003008', 'enhanced long-term potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332251, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004513', 'avnosmia', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332252, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003412', 'abnormal afterhyperpolarization', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332253, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332254, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0009244', 'abnormal acid-activated cation-mediated receptor currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332255, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0013438', 'dysmyelination', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332256, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332257, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332258, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002634', 'abnormal sensorimotor gating', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332259, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001496', 'audiogenic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332260, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332261, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332262, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332263, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002885', 'abnormal AMPA-mediated synaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332264, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332265, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332266, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332267, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332268, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0006051', 'brainstem hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332269, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332270, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332271, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0000950', 'abnormal seizure response to pharmacological agent', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332272, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332273, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332274, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332275, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332276, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332277, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332278, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332279, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332280, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0030129', 'tongue inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332281, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004008', 'abnormal GABA-mediated receptor currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332282, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332283, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0000951', 'sporadic seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332284, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001917', 'intraventricular hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332285, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332286, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332287, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332288, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003473', 'decreased summary potential threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332289, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332290, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332291, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332292, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332293, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332294, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332295, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0020154', 'impaired humoral immune response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332296, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332297, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332298, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332299, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332300, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332301, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332302, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332303, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332304, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332305, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332306, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001844', 'autoimmune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332307, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332308, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001902', 'reduced NMDA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332309, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332310, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332311, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332312, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332313, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332314, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332315, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332316, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003889', 'enhanced sensorimotor gating', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332317, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0020371', 'abnormal glymphatic system physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332318, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0003484', 'abnormal channel response', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332319, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0011272', 'short excitatory postsynaptic current rise time', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332320, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0001900', 'impaired synaptic plasticity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332321, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332322, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332323, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0008747', 'abnormal T cell anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332324, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332325, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332326, 'HP:0006834', 'Developmental stagnation at onset of seizures', 'MP:0014120', 'focal seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(332327, 'HP:0011235', 'Additional crus of antihelix', 'MP:0002177', 'abnormal outer ear morphology', 0.4090909090909091, 10.255471829629862, 2.048272514569165, 'UPHENO:0086699', 'abnormal external ear morphology'),
(332328, 'HP:0011235', 'Additional crus of antihelix', 'MP:0011495', 'abnormal head shape', 0.45454545454545453, 6.5236679405794336, 1.7220056937636088, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(332329, 'HP:0011235', 'Additional crus of antihelix', 'MP:0030071', 'abnormal face shape', 0.4166666666666667, 6.5236679405794336, 1.6486949309200385, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(332330, 'HP:0011235', 'Additional crus of antihelix', 'MP:0030074', 'coarse facial features', 0.40816326530612246, 6.5236679405794336, 1.6317847923055813, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(332331, 'HP:0011235', 'Additional crus of antihelix', 'MP:0003735', 'cup-shaped ears', 0.49019607843137253, 11.115294171581601, 2.3342394079272144, 'UPHENO:0005986', 'abnormal shape of external ear'),
(332332, 'HP:0011235', 'Additional crus of antihelix', 'MP:0009578', 'otocephaly', 0.4444444444444444, 6.5236679405794336, 1.7027648027813058, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(332333, 'HP:0011235', 'Additional crus of antihelix', 'MP:0000017', 'big ears', 0.42857142857142855, 10.255471829629862, 2.0964737567397576, 'UPHENO:0086699', 'abnormal external ear morphology'),
(332334, 'HP:0011235', 'Additional crus of antihelix', 'MP:0000053', 'excessive ear growth', 0.4117647058823529, 10.255471829629862, 2.0549553137750456, 'UPHENO:0086699', 'abnormal external ear morphology'),
(332335, 'HP:0011235', 'Additional crus of antihelix', 'MP:0000022', 'abnormal ear shape', 0.5555555555555556, 11.115294171581601, 2.484987611368806, 'UPHENO:0005986', 'abnormal shape of external ear'),
(332336, 'HP:0011235', 'Additional crus of antihelix', 'MP:0000018', 'small ears', 0.42857142857142855, 10.255471829629862, 2.0964737567397576, 'UPHENO:0086699', 'abnormal external ear morphology'),
(332337, 'HP:0011235', 'Additional crus of antihelix', 'MP:0006290', 'proboscis', 0.4444444444444444, 6.5236679405794336, 1.7027648027813058, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(332338, 'HP:0011235', 'Additional crus of antihelix', 'MP:0003713', 'abnormal ear rotation', 0.40384615384615385, 10.255471829629862, 2.035100207428027, 'UPHENO:0086699', 'abnormal external ear morphology'),
(332339, 'HP:0011235', 'Additional crus of antihelix', 'MP:0003736', 'folded helix', 0.44642857142857145, 11.115294171581601, 2.2275962152121513, 'UPHENO:0005986', 'abnormal shape of external ear'),
(332340, 'HP:0010779', 'Large pelvis bone', 'MP:0030823', 'increased femur size', 0.42424242424242425, 7.694257931681313, 1.806718195425889, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(332341, 'HP:0010779', 'Large pelvis bone', 'MP:0004692', 'small pubis', 0.40350877192982454, 12.192109768632433, 2.2180223713872884, 'UPHENO:0019394', 'abnormal pelvic girdle bone/zone morphology'),
(332342, 'HP:0010779', 'Large pelvis bone', 'MP:0004689', 'small ischium', 0.40350877192982454, 12.192109768632433, 2.2180223713872884, 'UPHENO:0019394', 'abnormal pelvic girdle bone/zone morphology'),
(332343, 'HP:0010779', 'Large pelvis bone', 'MP:0008158', 'increased diameter of femur', 0.4117647058823529, 7.694257931681313, 1.7799505201610848, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(332344, 'HP:0010779', 'Large pelvis bone', 'MP:0030849', 'wide ilium', 0.45614035087719296, 14.87018167374507, 2.6043981812061077, 'UPHENO:0001526', 'increased size of the pelvic girdle bone/zone'),
(332345, 'HP:0012085', 'Pyuria', 'MP:0000322', 'increased granulocyte number', 0.4174757281553398, 13.799792345853671, 2.400224647398186, 'UPHENO:0085497', 'abnormally increased number of granulocyte'),
(332346, 'HP:0012085', 'Pyuria', 'MP:0000219', 'increased neutrophil cell number', 0.42727272727272725, 15.607147267911275, 2.5823455187305098, 'UPHENO:0085939', 'abnormally increased number of neutrophil in the independent continuant'),
(332347, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332348, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001666', 'abnormal intestinal absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332349, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0011012', 'bronchiectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332350, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020154', 'impaired humoral immune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332351, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332352, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332353, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004751', 'increased length of allograft survival', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332354, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0010539', 'decreased level of surface class II molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332355, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005364', 'increased susceptibility to prion infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332356, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332357, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003303', 'peritoneal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332358, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004212', 'abnormal salty taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332359, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0011047', 'increased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332360, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001847', 'brain inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332361, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332362, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020142', 'increased anti-sperm antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332363, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332364, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005399', 'increased susceptibility to fungal infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332365, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020386', 'adipose tissue inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332366, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332367, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332368, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003866', 'abnormal defecation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332369, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008271', 'abnormal bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332370, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020001', 'decreased response to antigen', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332371, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008666', 'increased interleukin-12a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332372, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332373, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0031089', 'sneezing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332374, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332375, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0011043', 'abnormal lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332376, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332377, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0031170', 'abnormal vasculature physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332378, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005363', 'decreased susceptibility to prion infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332379, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332380, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001864', 'vascular inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332381, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332382, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0010381', 'abnormal dosage compensation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332383, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332384, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004994', 'abnormal brain wave pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332385, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001866', 'nasal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332386, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332387, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332388, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0031053', 'pleuritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332389, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004211', 'abnormal sour taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332390, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332391, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003091', 'abnormal cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332392, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0010211', 'abnormal acute phase protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332393, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002723', 'abnormal immune serum protein physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332394, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008722', 'abnormal chemokine secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332395, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332396, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001837', 'defective assembly of class I molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332397, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003412', 'abnormal afterhyperpolarization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332398, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332399, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332400, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332401, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008721', 'abnormal chemokine level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332402, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001984', 'abnormal olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332403, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002254', 'reproductive system inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332404, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008687', 'increased interleukin-2 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332405, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332406, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008747', 'abnormal T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332407, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332408, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002128', 'abnormal blood circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332409, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332410, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0030988', 'dysosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332411, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008942', 'abnormal induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332412, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008562', 'increased interferon-alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332413, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332414, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0021016', 'decreased tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332415, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008544', 'impaired olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332416, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332417, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0030132', 'periodontium inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332418, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0000743', 'muscle spasm', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332419, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001845', 'abnormal inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332420, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0012554', 'increased serum complement activity', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332421, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001194', 'dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332422, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0011925', 'abnormal heart echocardiography feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332423, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0031098', 'abnormal sputum production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332424, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003726', 'decreased autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332425, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332426, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332427, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002693', 'abnormal pancreas physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332428, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332429, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0012111', 'failure of morula compaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332430, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004143', 'muscle hypertonia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332431, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332432, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003633', 'abnormal nervous system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332433, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0030909', 'abnormal melanocyte adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332434, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003725', 'increased autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332435, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001849', 'ear inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332436, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0010377', 'abnormal gut flora balance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332437, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001921', 'reduced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332438, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332439, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0031095', 'pharyngitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332440, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332441, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002500', 'granulomatous inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332442, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005042', 'abnormal level of surface class II molecules', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332443, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332444, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005001', 'abnormal clonal deletion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332445, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001947', 'abnormal mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332446, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003280', 'urinary incontinence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332447, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0009473', 'abnormal skin exfoliation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332448, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0009062', 'impaired lectin complement pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332449, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332450, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0030990', 'nerve inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332451, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0031088', 'coughing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332452, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0013136', 'genital discharge', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332453, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332454, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332455, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332456, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332457, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332458, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332459, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332460, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0031125', 'aspiration pneumonia', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332461, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332462, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332463, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0011048', 'decreased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332464, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0031110', 'meningitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332465, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0031092', 'dysgeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332466, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332467, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004510', 'myositis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332468, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0011763', 'urethritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332469, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332470, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332471, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003477', 'abnormal nerve fiber response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332472, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332473, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332474, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332475, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0031402', 'decreased muscle fatigability', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332476, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332477, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008684', 'increased interleukin-18 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332478, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0013475', 'delayed reproductive senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332479, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002420', 'abnormal adaptive immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332480, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008696', 'increased interleukin-3 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332481, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004213', 'abnormal umami taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332482, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003566', 'abnormal cell adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332483, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003865', 'lymph node inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332484, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332485, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003077', 'abnormal cell cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332486, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002106', 'abnormal muscle physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332487, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005025', 'abnormal response to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332488, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332489, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332490, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0011082', 'abnormal gastrointestinal motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332491, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002314', 'abnormal respiratory mechanics', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332492, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332493, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332494, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332495, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003674', 'oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332496, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0011764', 'ureteritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332497, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332498, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332499, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004046', 'abnormal mitosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332500, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0031169', 'abnormal joint physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332501, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332502, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332503, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332504, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332505, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0000501', 'abnormal digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332506, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0031090', 'ageusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332507, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002419', 'abnormal innate immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332508, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008711', 'increased interleukin-9 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332509, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332510, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332511, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332512, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001636', 'irregular heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332513, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332514, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332515, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001924', 'infertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332516, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0000351', 'increased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332517, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004085', 'abnormal heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332518, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332519, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003878', 'abnormal ear physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332520, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001876', 'decreased inflammatory response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332521, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004037', 'increased muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332522, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004512', 'anosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332523, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332524, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0000738', 'impaired muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332525, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003470', 'abnormal summary potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332526, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332527, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332528, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008737', 'abnormal spleen physiology', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332529, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0030924', 'early exit from telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332530, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002634', 'abnormal sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332531, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332532, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332533, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332534, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0014037', 'stranguria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332535, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0010994', 'aerophagia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332536, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002498', 'abnormal acute inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332537, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0011399', 'increased endoneurial fluid pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332538, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332539, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002896', 'abnormal bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332540, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008004', 'abnormal stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332541, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332542, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332543, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332544, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332545, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0010922', 'alveolitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332546, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0031221', 'abnormal CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332547, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332548, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0006114', 'cardiac murmur', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332549, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002406', 'increased susceptibility to infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332550, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005403', 'abnormal nerve conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332551, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332552, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003009', 'abnormal cytokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332553, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008272', 'abnormal endochondral bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332554, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005620', 'abnormal muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332555, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0031013', 'abnormal egg activation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332556, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005532', 'abnormal vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332557, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008678', 'increased interleukin-16 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332558, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332559, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0000751', 'myopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332560, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332561, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332562, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332563, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332564, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020155', 'enhanced humoral immune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332565, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002471', 'abnormal complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332566, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001793', 'abnormal susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332567, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020846', 'abnormal cell motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332568, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332569, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008660', 'increased interleukin-10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332570, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008705', 'increased interleukin-6 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332571, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0012556', 'increased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332572, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001839', 'abnormal level of surface class I molecules', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332573, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332574, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003463', 'abnormal single cell response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332575, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0000316', 'cellular necrosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332576, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0010680', 'abnormal skin adnexa physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332577, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004142', 'abnormal muscle tone', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332578, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332579, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0013639', 'decreased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332580, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008568', 'abnormal interleukin secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332581, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001800', 'abnormal humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332582, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332583, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002164', 'abnormal gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332584, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332585, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332586, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332587, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0011926', 'abnormal heart valve physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332588, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332589, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332590, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020040', 'decreased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332591, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332592, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332593, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332594, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001533', 'abnormal skeleton physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332595, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332596, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0009057', 'increased interleukin-21 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332597, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332598, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0031222', 'decreased CXCL10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332599, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332600, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001933', 'abnormal litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332601, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332602, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0000304', 'abnormal cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332603, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005000', 'abnormal immune tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332604, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002327', 'abnormal respiratory function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332605, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332606, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001840', 'increased level of surface class I molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332607, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008702', 'increased interleukin-5 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332608, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001841', 'decreased level of surface class I molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332609, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332610, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332611, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0011431', 'increased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332612, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332613, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002410', 'decreased susceptibility to viral infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332614, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332615, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332616, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0010753', 'improved mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332617, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0031240', 'abnormal CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332618, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020097', 'low mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332619, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0031054', 'bronchiolitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332620, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002473', 'impaired complement classical pathway', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332621, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0010752', 'impaired mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332622, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332623, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332624, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008694', 'decreased interleukin-23a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332625, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332626, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0031055', 'bronchitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332627, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001542', 'abnormal bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332628, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001914', 'hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332629, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0012006', 'abnormal hippocampus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332630, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0013942', 'enthesitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332631, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332632, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0011566', 'abnormal complement protein level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332633, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001835', 'abnormal antigen presentation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332634, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332635, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020371', 'abnormal glymphatic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332636, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005088', 'increased acute inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332637, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003927', 'increased cellular glucose import', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332638, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008565', 'decreased interferon-beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332639, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001872', 'sinus inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332640, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008699', 'increased interleukin-4 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332641, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003298', 'choking', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332642, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001867', 'rhinitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332643, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004945', 'abnormal bone resorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332644, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332645, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332646, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003875', 'abnormal hair follicle regression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332647, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332648, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002133', 'abnormal respiratory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332649, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0013498', 'trachea inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332650, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332651, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332652, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003926', 'decreased cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332653, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008555', 'abnormal interferon secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332654, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004036', 'abnormal muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332655, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001627', 'abnormal cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332656, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332657, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0030153', 'dental pulp inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332658, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001844', 'autoimmune response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332659, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332660, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005190', 'osteomyelitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332661, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008566', 'increased interferon-gamma secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332662, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002405', 'respiratory system inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332663, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0012382', 'abnormal blood cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332664, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332665, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002322', 'abnormal respiratory transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332666, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008861', 'abnormal hair shedding', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332667, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332668, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001986', 'abnormal taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332669, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332670, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0011717', 'increased interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332671, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001862', 'interstitial pneumonia', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332672, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005501', 'abnormal skin physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332673, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0006138', 'congestive heart failure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332674, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332675, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0010143', 'enhanced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332676, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005005', 'abnormal self tolerance', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332677, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332678, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002933', 'joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332679, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332680, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332681, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332682, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005410', 'abnormal fertilization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332683, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332684, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0012565', 'perivasculitis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332685, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332686, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0031066', 'cytokine storm', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332687, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008651', 'increased interleukin-1 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332688, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332689, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0031102', 'rhinorrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332690, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004145', 'abnormal muscle electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332691, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332692, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332693, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0011432', 'decreased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332694, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0009046', 'muscle twitch', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332695, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005044', 'sepsis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332696, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005076', 'abnormal cell differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332697, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332698, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0014274', 'decreased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332699, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332700, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332701, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332702, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332703, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0010538', 'increased level of surface class II molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332704, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332705, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0000427', 'abnormal hair cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332706, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003777', 'lip inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332707, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004072', 'abnormal frontal plane axis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332708, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005402', 'abnormal action potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332709, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332710, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008006', 'increased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332711, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332712, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0031111', 'meningoencephalitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332713, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332714, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003868', 'abnormal feces composition', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332715, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004796', 'increased anti-histone antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332716, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001983', 'abnormal olfactory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332717, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004558', 'delayed allantois development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332718, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020848', 'abnormal exocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332719, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004009', 'abnormal diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332720, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008005', 'decreased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332721, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0030987', 'spinal cord inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332722, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332723, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332724, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003889', 'enhanced sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332725, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332726, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0011046', 'abnormal lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332727, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003659', 'abnormal lymph circulation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332728, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004752', 'decreased length of allograft survival', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332729, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008708', 'increased interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332730, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003278', 'esophageal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332731, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0010559', 'heart block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332732, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332733, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332734, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003925', 'abnormal cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332735, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332736, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0006080', 'brain ischemia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332737, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001869', 'pancreas inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332738, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0006082', 'CNS inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332739, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332740, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0000350', 'abnormal cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332741, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008558', 'abnormal interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332742, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0030129', 'tongue inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332743, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0000352', 'decreased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332744, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002472', 'impaired complement alternative pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332745, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332746, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332747, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0013559', 'abnormal exocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332748, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003762', 'abnormal immune organ physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332749, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332750, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001846', 'increased inflammatory response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332751, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005666', 'abnormal adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332752, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0010950', 'abnormal lung hysteresivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332753, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332754, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332755, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332756, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008713', 'abnormal cytokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332757, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0013806', 'encephalopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332758, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0010822', 'pneumothorax', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332759, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008663', 'increased interleukin-12 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332760, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332761, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0010695', 'abnormal blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332762, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001663', 'abnormal digestive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332763, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003259', 'nausea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332764, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005087', 'decreased acute inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332765, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332766, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002418', 'increased susceptibility to viral infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332767, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332768, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001790', 'abnormal immune system physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332769, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008748', 'abnormal central T cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332770, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332771, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332772, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332773, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332774, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332775, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0000423', 'delayed hair regrowth', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332776, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001985', 'abnormal gustatory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332777, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003880', 'abnormal central pattern generator function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332778, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332779, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332780, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332781, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332782, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002499', 'chronic inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332783, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008750', 'abnormal interferon level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332784, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003746', 'stomatitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332785, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0011762', 'renal/urinary system inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332786, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332787, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005275', 'abnormal skin tensile strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332788, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008667', 'decreased interleukin-12a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332789, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001629', 'abnormal heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332790, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001633', 'poor circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332791, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003767', 'palate inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332792, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008669', 'increased interleukin-12b secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332793, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332794, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0009697', 'abnormal copulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332795, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003260', 'vomiting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332796, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020412', 'abnormal amnion physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332797, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002998', 'abnormal bone remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332798, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332799, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008675', 'increased interleukin-15 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332800, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0031128', 'cardiovascular shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332801, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003157', 'impaired muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332802, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332803, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008681', 'increased interleukin-17 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332804, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008564', 'increased interferon-beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332805, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0013640', 'increased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332806, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0014048', 'abnormal Peyers patch physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332807, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008693', 'increased interleukin-23a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332808, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332809, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001664', 'abnormal digestion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332810, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005671', 'abnormal response to transplant', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332811, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332812, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020096', 'high mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332813, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0031091', 'hypogeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332814, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0013971', 'blood in lymph vessels', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332815, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008775', 'abnormal heart ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332816, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332817, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332818, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0000313', 'abnormal cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332819, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332820, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332821, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0021015', 'increased tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332822, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332823, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0012555', 'decreased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332824, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008690', 'increased interleukin-23 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332825, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0010071', 'abnormal pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332826, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0030130', 'gum inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332827, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0030214', 'muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332828, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008744', 'abnormal B cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332829, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332830, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332831, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004947', 'skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332832, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003186', 'abnormal redox activity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332833, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0030991', 'optic nerve inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332834, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332835, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001761', 'abnormal urination pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332836, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008672', 'increased interleukin-13 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332837, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005043', 'defective assembly of class II molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332838, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332839, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020039', 'increased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332840, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332841, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004829', 'increased anti-chromatin antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332842, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0011044', 'increased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332843, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332844, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008751', 'abnormal interleukin level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332845, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332846, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332847, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332848, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001943', 'abnormal respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332849, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0012685', 'abnormal primitive streak elongation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332850, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0003621', 'dysuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332851, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332852, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0013636', 'abnormal bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332853, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002161', 'abnormal fertility/fecundity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332854, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001756', 'abnormal urination', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332855, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332856, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020381', 'muscle gating pore current', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332857, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004782', 'abnormal surfactant physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332858, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020002', 'increased response to antigen', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332859, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002635', 'reduced sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332860, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332861, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332862, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0031302', 'syncope', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332863, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0006001', 'abnormal intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332864, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332865, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332866, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001861', 'lung inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332867, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002421', 'abnormal cell-mediated immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332868, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332869, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001819', 'abnormal immune cell physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332870, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332871, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0005621', 'abnormal cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332872, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332873, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332874, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001648', 'abnormal apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332875, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332876, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332877, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332878, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332879, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332880, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002409', 'decreased susceptibility to infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332881, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0031223', 'increased CXCL10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332882, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332883, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0012553', 'decreased serum complement activity', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332884, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0009562', 'abnormal odor adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332885, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332886, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332887, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001950', 'abnormal respiratory sounds', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332888, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0030951', 'abnormal endocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332889, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332890, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001873', 'stomach inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332891, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0013561', 'abnormal endocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332892, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0031009', 'abnormal sperm-egg fusion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332893, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004149', 'increased bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332894, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0001919', 'abnormal reproductive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332895, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332896, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0011045', 'decreased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332897, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0020000', 'abnormal response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332898, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(332899, 'HP:0033141', 'Severe SARS-CoV-2 infection', 'MP:0014275', 'increased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(332900, 'HP:0011616', 'Pulmonary situs inversus', 'MP:0002133', 'abnormal respiratory system physiology', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(332901, 'HP:0011616', 'Pulmonary situs inversus', 'MP:0002306', 'abnormal functional residual capacity', 0.4878048780487805, 9.915985363358194, 2.1993330877578403, 'UPHENO:0019970', 'abnormal lung morphology'),
(332902, 'HP:0011616', 'Pulmonary situs inversus', 'MP:0010937', 'increased total lung capacity', 0.46511627906976744, 9.915985363358194, 2.1475768241242124, 'UPHENO:0019970', 'abnormal lung morphology'),
(332903, 'HP:0011616', 'Pulmonary situs inversus', 'MP:0002312', 'abnormal inspiratory reserve volume', 0.4878048780487805, 9.915985363358194, 2.1993330877578403, 'UPHENO:0019970', 'abnormal lung morphology'),
(332904, 'HP:0011616', 'Pulmonary situs inversus', 'MP:0003641', 'small lung', 0.4146341463414634, 9.915985363358194, 2.0276849178978646, 'UPHENO:0019970', 'abnormal lung morphology'),
(332905, 'HP:0011616', 'Pulmonary situs inversus', 'MP:0003298', 'choking', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(332906, 'HP:0011616', 'Pulmonary situs inversus', 'MP:0011046', 'abnormal lung tissue damping', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(332907, 'HP:0011616', 'Pulmonary situs inversus', 'MP:0002308', 'abnormal residual volume', 0.4878048780487805, 9.915985363358194, 2.1993330877578403, 'UPHENO:0019970', 'abnormal lung morphology'),
(332908, 'HP:0011616', 'Pulmonary situs inversus', 'MP:0001942', 'abnormal lung volume', 0.5, 9.915985363358194, 2.2266550432608767, 'UPHENO:0019970', 'abnormal lung morphology'),
(332909, 'HP:0011616', 'Pulmonary situs inversus', 'MP:0011163', 'increased wet-to-dry lung weight ratio', 0.40476190476190477, 9.915985363358194, 2.00340039015271, 'UPHENO:0019970', 'abnormal lung morphology'),
(332910, 'HP:0011616', 'Pulmonary situs inversus', 'MP:0001958', 'emphysema', 0.4146341463414634, 9.150450616995217, 1.9478422113245026, 'UPHENO:0086908', 'abnormal lung morphology'),
(332911, 'HP:0011616', 'Pulmonary situs inversus', 'MP:0002337', 'abnormal whole-body plethysmography', 0.4878048780487805, 9.915985363358194, 2.1993330877578403, 'UPHENO:0019970', 'abnormal lung morphology'),
(332912, 'HP:0011616', 'Pulmonary situs inversus', 'MP:0001943', 'abnormal respiration', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(332913, 'HP:0011616', 'Pulmonary situs inversus', 'MP:0002304', 'abnormal total lung capacity', 0.47619047619047616, 9.915985363358194, 2.172992819149509, 'UPHENO:0019970', 'abnormal lung morphology'),
(332914, 'HP:0011616', 'Pulmonary situs inversus', 'MP:0001947', 'abnormal mucociliary clearance', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(332915, 'HP:0011616', 'Pulmonary situs inversus', 'MP:0002311', 'abnormal inspiratory capacity', 0.4878048780487805, 9.915985363358194, 2.1993330877578403, 'UPHENO:0019970', 'abnormal lung morphology'),
(332916, 'HP:0011616', 'Pulmonary situs inversus', 'MP:0010950', 'abnormal lung hysteresivity', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(332917, 'HP:0011616', 'Pulmonary situs inversus', 'MP:0003426', 'pulmonary interstitial fibrosis', 0.40476190476190477, 9.915985363358194, 2.00340039015271, 'UPHENO:0019970', 'abnormal lung morphology'),
(332918, 'HP:0011616', 'Pulmonary situs inversus', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(332919, 'HP:0011616', 'Pulmonary situs inversus', 'MP:0005629', 'abnormal lung weight', 0.425, 9.915985363358194, 2.052874516239907, 'UPHENO:0019970', 'abnormal lung morphology'),
(332920, 'HP:0011616', 'Pulmonary situs inversus', 'MP:0002309', 'abnormal vital capacity', 0.4878048780487805, 9.915985363358194, 2.1993330877578403, 'UPHENO:0019970', 'abnormal lung morphology'),
(332921, 'HP:0011616', 'Pulmonary situs inversus', 'MP:0002313', 'abnormal tidal volume', 0.4878048780487805, 9.915985363358194, 2.1993330877578403, 'UPHENO:0019970', 'abnormal lung morphology'),
(332922, 'HP:0011616', 'Pulmonary situs inversus', 'MP:0010857', 'pulmonary necrosis', 0.4418604651162791, 9.915985363358194, 2.093198964441667, 'UPHENO:0019970', 'abnormal lung morphology'),
(332923, 'HP:0011616', 'Pulmonary situs inversus', 'MP:0031102', 'rhinorrhea', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(332924, 'HP:0011616', 'Pulmonary situs inversus', 'MP:0010822', 'pneumothorax', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(332925, 'HP:0011616', 'Pulmonary situs inversus', 'MP:0005585', 'increased tidal volume', 0.47619047619047616, 9.915985363358194, 2.172992819149509, 'UPHENO:0019970', 'abnormal lung morphology'),
(332926, 'HP:0011616', 'Pulmonary situs inversus', 'MP:0011043', 'abnormal lung elastance', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(332927, 'HP:0011616', 'Pulmonary situs inversus', 'MP:0005586', 'decreased tidal volume', 0.47619047619047616, 9.915985363358194, 2.172992819149509, 'UPHENO:0019970', 'abnormal lung morphology'),
(332928, 'HP:0011616', 'Pulmonary situs inversus', 'MP:0010938', 'decreased total lung capacity', 0.46511627906976744, 9.915985363358194, 2.1475768241242124, 'UPHENO:0019970', 'abnormal lung morphology'),
(332929, 'HP:0011616', 'Pulmonary situs inversus', 'MP:0006050', 'pulmonary fibrosis', 0.4594594594594595, 9.915985363358194, 2.1344772837995882, 'UPHENO:0019970', 'abnormal lung morphology'),
(332930, 'HP:0011616', 'Pulmonary situs inversus', 'MP:0003828', 'pulmonary edema', 0.4146341463414634, 9.915985363358194, 2.0276849178978646, 'UPHENO:0019970', 'abnormal lung morphology'),
(332931, 'HP:0011616', 'Pulmonary situs inversus', 'MP:0031088', 'coughing', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(332932, 'HP:0011616', 'Pulmonary situs inversus', 'MP:0011162', 'abnormal wet-to-dry lung weight ratio', 0.4146341463414634, 9.915985363358194, 2.0276849178978646, 'UPHENO:0019970', 'abnormal lung morphology'),
(332933, 'HP:0011616', 'Pulmonary situs inversus', 'MP:0031089', 'sneezing', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(332934, 'HP:0011616', 'Pulmonary situs inversus', 'MP:0031098', 'abnormal sputum production', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(332935, 'HP:0011616', 'Pulmonary situs inversus', 'MP:0004881', 'abnormal lung size', 0.4594594594594595, 9.915985363358194, 2.1344772837995882, 'UPHENO:0019970', 'abnormal lung morphology'),
(332936, 'HP:0007380', 'Facial telangiectasia', 'MP:0002060', 'abnormal skin morphology', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(332937, 'HP:0000472', 'Long neck', 'MP:0001256', 'abnormal body length', 0.40540540540540543, 7.889470844844879, 1.7884166534363475, 'UPHENO:0088186', 'abnormal anatomical entity length'),
(332938, 'HP:0000472', 'Long neck', 'MP:0002758', 'long tail', 0.5, 10.073168695908924, 2.244233576959952, 'UPHENO:0055730', 'increased anatomical entity length in independent continuant'),
(332939, 'HP:0000472', 'Long neck', 'MP:0000548', 'long limbs', 0.5, 10.073168695908924, 2.244233576959952, 'UPHENO:0055730', 'increased anatomical entity length in independent continuant'),
(332940, 'HP:0000472', 'Long neck', 'MP:0012720', 'elongated neck', 0.6666666666666666, 16.607147267911277, 3.3273760701100277, 'UPHENO:0072272', 'increased length of the neck'),
(332941, 'HP:0000472', 'Long neck', 'MP:0004695', 'increased length of long bones', 0.4523809523809524, 10.073168695908924, 2.1346919328440053, 'UPHENO:0055730', 'increased anatomical entity length in independent continuant'),
(332942, 'HP:0000472', 'Long neck', 'MP:0011496', 'abnormal head size', 0.41025641025641024, 4.671736632292707, 1.3844168087782585, 'UPHENO:0075195', 'abnormal size of anatomical entity'),
(332943, 'HP:0000472', 'Long neck', 'MP:0020085', 'long ears', 0.4375, 10.073168695908924, 2.0992882852195778, 'UPHENO:0055730', 'increased anatomical entity length in independent continuant'),
(332944, 'HP:0000472', 'Long neck', 'MP:0001264', 'increased body size', 0.43243243243243246, 5.9605885577567275, 1.6054755709009296, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(332945, 'HP:0000472', 'Long neck', 'MP:0004556', 'enlarged allantois', 0.42105263157894735, 5.9605885577567275, 1.5842100548862934, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(332946, 'HP:0000472', 'Long neck', 'MP:0001300', 'ocular hypertelorism', 0.42, 10.073168695908924, 2.0568740487160966, 'UPHENO:0055730', 'increased anatomical entity length in independent continuant'),
(332947, 'HP:0000472', 'Long neck', 'MP:0030345', 'enlarged maxillary prominence', 0.43902439024390244, 5.9605885577567275, 1.617666145118927, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(332948, 'HP:0000472', 'Long neck', 'MP:0012160', 'expanded anterior visceral endoderm', 0.42105263157894735, 5.9605885577567275, 1.5842100548862934, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(332949, 'HP:0000472', 'Long neck', 'MP:0013954', 'increased intestine length', 0.4523809523809524, 10.073168695908924, 2.1346919328440053, 'UPHENO:0055730', 'increased anatomical entity length in independent continuant'),
(332950, 'HP:0000472', 'Long neck', 'MP:0013328', 'visceromegaly', 0.4444444444444444, 5.9605885577567275, 1.6276211076642195, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(332951, 'HP:0000472', 'Long neck', 'MP:0030166', 'increased inner canthal distance', 0.42, 10.073168695908924, 2.0568740487160966, 'UPHENO:0055730', 'increased anatomical entity length in independent continuant'),
(332952, 'HP:0000472', 'Long neck', 'MP:0001268', 'barrel chest', 0.42105263157894735, 5.9605885577567275, 1.5842100548862934, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(332953, 'HP:0000472', 'Long neck', 'MP:0004671', 'long ribs', 0.4418604651162791, 10.073168695908924, 2.1097239168121167, 'UPHENO:0055730', 'increased anatomical entity length in independent continuant'),
(332954, 'HP:0000472', 'Long neck', 'MP:0001281', 'increased vibrissae length', 0.475, 10.073168695908924, 2.1874083136343656, 'UPHENO:0055730', 'increased anatomical entity length in independent continuant'),
(332955, 'HP:0000472', 'Long neck', 'MP:0011999', 'abnormal tail length', 0.4166666666666667, 7.889470844844879, 1.8130856346806585, 'UPHENO:0088186', 'abnormal anatomical entity length'),
(332956, 'HP:0000472', 'Long neck', 'MP:0000446', 'long snout', 0.45652173913043476, 10.073168695908924, 2.1444394352861997, 'UPHENO:0055730', 'increased anatomical entity length in independent continuant'),
(332957, 'HP:0000472', 'Long neck', 'MP:0030070', 'long face', 0.44680851063829785, 10.073168695908924, 2.1215035947241265, 'UPHENO:0055730', 'increased anatomical entity length in independent continuant'),
(332958, 'HP:0000472', 'Long neck', 'MP:0000588', 'thick tail', 0.41025641025641024, 5.9605885577567275, 1.5637677783867745, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(332959, 'HP:0000472', 'Long neck', 'MP:0001267', 'enlarged chest', 0.43243243243243246, 5.9605885577567275, 1.6054755709009296, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(332960, 'HP:0000472', 'Long neck', 'MP:0031094', 'organomegaly', 0.47058823529411764, 5.9605885577567275, 1.6748083026749803, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(332961, 'HP:0000472', 'Long neck', 'MP:0006296', 'arachnodactyly', 0.4418604651162791, 10.073168695908924, 2.1097239168121167, 'UPHENO:0055730', 'increased anatomical entity length in independent continuant'),
(332962, 'HP:0000472', 'Long neck', 'MP:0013959', 'increased large intestine length', 0.41304347826086957, 10.073168695908924, 2.039768770048882, 'UPHENO:0055730', 'increased anatomical entity length in independent continuant'),
(332963, 'HP:0000472', 'Long neck', 'MP:0012721', 'short neck', 0.4634146341463415, 11.15868676709498, 2.2740050012537223, 'UPHENO:0087563', 'abnormal neck morphology'),
(332964, 'HP:0000472', 'Long neck', 'MP:0000434', 'megacephaly', 0.43902439024390244, 5.9605885577567275, 1.617666145118927, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(332965, 'HP:0000472', 'Long neck', 'MP:0020302', 'large horns', 0.43902439024390244, 5.9605885577567275, 1.617666145118927, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(332966, 'HP:0000472', 'Long neck', 'MP:0001257', 'increased body length', 0.4634146341463415, 10.073168695908924, 2.160567931334031, 'UPHENO:0055730', 'increased anatomical entity length in independent continuant'),
(332967, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0013126', 'teat swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(332968, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0000003', 'abnormal adipose tissue morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(332969, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0002085', 'abnormal embryonic tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(332970, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0013558', 'abnormal exocrine gland morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(332971, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.4166666666666667, 4.8755453832354885, 1.4252990012677296, 'UPHENO:0086172', 'abnormal cell'),
(332972, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0005508', 'abnormal skeleton morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(332973, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(332974, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0005360', 'urolithiasis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(332975, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0011199', 'abnormal amniotic cavity morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(332976, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0005500', 'abnormal gustatory system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(332977, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0030951', 'abnormal endocytosis', 0.4166666666666667, 4.8755453832354885, 1.4252990012677296, 'UPHENO:0086172', 'abnormal cell'),
(332978, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0003119', 'abnormal digestive system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(332979, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0003385', 'abnormal body wall morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(332980, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0004046', 'abnormal mitosis', 0.4166666666666667, 4.8755453832354885, 1.4252990012677296, 'UPHENO:0086172', 'abnormal cell'),
(332981, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0010736', 'abnormal extraembryonic ectoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(332982, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0013283', 'failure of ventral body wall closure', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(332983, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0000313', 'abnormal cell death', 0.43478260869565216, 4.8755453832354885, 1.4559540997356917, 'UPHENO:0086172', 'abnormal cell'),
(332984, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0002132', 'abnormal respiratory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(332985, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0020848', 'abnormal exocytosis', 0.4166666666666667, 4.8755453832354885, 1.4252990012677296, 'UPHENO:0086172', 'abnormal cell'),
(332986, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0003384', 'abnormal ventral body wall morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(332987, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0010678', 'abnormal skin adnexa morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(332988, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0003935', 'abnormal craniofacial development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(332989, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0000752', 'dystrophic muscle', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(332990, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0031274', 'increased susceptibility to induced aneurysm formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(332991, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0002163', 'abnormal gland morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(332992, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0011174', 'lipodystrophy', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(332993, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0005457', 'abnormal percent body fat/body weight', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(332994, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0000316', 'cellular necrosis', 0.4166666666666667, 4.8755453832354885, 1.4252990012677296, 'UPHENO:0086172', 'abnormal cell'),
(332995, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0001985', 'abnormal gustatory system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(332996, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0000351', 'increased cell proliferation', 0.4166666666666667, 4.8755453832354885, 1.4252990012677296, 'UPHENO:0086172', 'abnormal cell'),
(332997, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0013122', 'tail swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(332998, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0001726', 'abnormal allantois morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(332999, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0003925', 'abnormal cellular glucose uptake', 0.43478260869565216, 4.8755453832354885, 1.4559540997356917, 'UPHENO:0086172', 'abnormal cell'),
(333000, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0010126', 'abnormal distal visceral endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333001, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0020981', 'abnormal immune system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333002, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0000428', 'abnormal craniofacial morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333003, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0013123', 'head/neck swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333004, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0000358', 'abnormal cell morphology', 0.45454545454545453, 4.8755453832354885, 1.4886762550601012, 'UPHENO:0086172', 'abnormal cell'),
(333005, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0003795', 'abnormal bone structure', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333006, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0012500', 'abnormal angioblastic cord morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333007, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0013124', 'mouth swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333008, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0002109', 'abnormal limb morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333009, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0003300', 'gastrointestinal ulcer', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333010, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0002111', 'abnormal tail morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333011, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0014134', 'abnormal embryo morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333012, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0003890', 'abnormal embryonic-extraembryonic boundary morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333013, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0031099', 'abnormal sputum morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333014, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0003927', 'increased cellular glucose import', 0.4166666666666667, 4.8755453832354885, 1.4252990012677296, 'UPHENO:0086172', 'abnormal cell'),
(333015, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0002836', 'abnormal chorion morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333016, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333017, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.43478260869565216, 4.8755453832354885, 1.4559540997356917, 'UPHENO:0086172', 'abnormal cell'),
(333018, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0005621', 'abnormal cell physiology', 0.45454545454545453, 4.8755453832354885, 1.4886762550601012, 'UPHENO:0086172', 'abnormal cell'),
(333019, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0002164', 'abnormal gland physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333020, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0010352', 'gastrointestinal tract polyps', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333021, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0003566', 'abnormal cell adhesion', 0.43478260869565216, 4.8755453832354885, 1.4559540997356917, 'UPHENO:0086172', 'abnormal cell'),
(333022, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0004134', 'abnormal chest morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333023, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0008923', 'thoracoschisis', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333024, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0010680', 'abnormal skin adnexa physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333025, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0014062', 'nervous system inclusion bodies', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333026, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0003861', 'abnormal nervous system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333027, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0003674', 'oxidative stress', 0.4166666666666667, 4.8755453832354885, 1.4252990012677296, 'UPHENO:0086172', 'abnormal cell'),
(333028, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0013258', 'abnormal extracellular matrix morphology', 0.45454545454545453, 4.8755453832354885, 1.4886762550601012, 'UPHENO:0086172', 'abnormal cell'),
(333029, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0002210', 'abnormal sex determination', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333030, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0012555', 'decreased cell death', 0.4166666666666667, 4.8755453832354885, 1.4252990012677296, 'UPHENO:0086172', 'abnormal cell'),
(333031, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0004272', 'abnormal basement membrane morphology', 0.4166666666666667, 4.8755453832354885, 1.4252990012677296, 'UPHENO:0086172', 'abnormal cell'),
(333032, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0001648', 'abnormal apoptosis', 0.4166666666666667, 4.8755453832354885, 1.4252990012677296, 'UPHENO:0086172', 'abnormal cell'),
(333033, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0003942', 'abnormal urinary system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333034, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0003632', 'abnormal nervous system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333035, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0020973', 'abnormal gland development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333036, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333037, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0003279', 'aneurysm', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333038, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0003936', 'abnormal reproductive system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333039, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0013113', 'greasy tail', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333040, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0012260', 'encephalomeningocele', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333041, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0002108', 'abnormal muscle morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333042, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0001929', 'abnormal gametogenesis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333043, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0005499', 'abnormal olfactory system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333044, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0000685', 'abnormal immune system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333045, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333046, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0013177', 'abnormal tail tip morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333047, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0008533', 'abnormal anterior visceral endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333048, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0001718', 'abnormal visceral yolk sac morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333049, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333050, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0013332', 'peliosis', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333051, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0000352', 'decreased cell proliferation', 0.4166666666666667, 4.8755453832354885, 1.4252990012677296, 'UPHENO:0086172', 'abnormal cell'),
(333052, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0031277', 'pectus carinatum', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333053, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333054, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0009840', 'abnormal foam cell morphology', 0.4166666666666667, 4.8755453832354885, 1.4252990012677296, 'UPHENO:0086172', 'abnormal cell'),
(333055, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0030909', 'abnormal melanocyte adhesion', 0.4166666666666667, 4.8755453832354885, 1.4252990012677296, 'UPHENO:0086172', 'abnormal cell'),
(333056, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0013133', 'pale limbs', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333057, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0013121', 'testicular swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333058, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0030572', 'abnormal pilosebaceous unit morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333059, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0013118', 'swellings', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333060, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.4166666666666667, 4.8755453832354885, 1.4252990012677296, 'UPHENO:0086172', 'abnormal cell'),
(333061, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0013119', 'abdomen swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333062, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0003115', 'abnormal respiratory system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333063, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0000266', 'abnormal heart morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333064, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0010381', 'abnormal dosage compensation', 0.4166666666666667, 4.8755453832354885, 1.4252990012677296, 'UPHENO:0086172', 'abnormal cell'),
(333065, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333066, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0002925', 'abnormal cardiovascular development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333067, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0010478', 'intracranial aneurysm', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333068, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.4166666666666667, 4.8755453832354885, 1.4252990012677296, 'UPHENO:0086172', 'abnormal cell'),
(333069, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0003926', 'decreased cellular glucose uptake', 0.4166666666666667, 4.8755453832354885, 1.4252990012677296, 'UPHENO:0086172', 'abnormal cell'),
(333070, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0003186', 'abnormal redox activity', 0.43478260869565216, 4.8755453832354885, 1.4559540997356917, 'UPHENO:0086172', 'abnormal cell'),
(333071, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0012514', 'pectus excavatum', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333072, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0006279', 'abnormal limb development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333073, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0000350', 'abnormal cell proliferation', 0.43478260869565216, 4.8755453832354885, 1.4559540997356917, 'UPHENO:0086172', 'abnormal cell'),
(333074, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0011200', 'abnormal extraembryonic coelom morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333075, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0006281', 'abnormal tail development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333076, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333077, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0012556', 'increased cell death', 0.4166666666666667, 4.8755453832354885, 1.4252990012677296, 'UPHENO:0086172', 'abnormal cell'),
(333078, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0001983', 'abnormal olfactory system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333079, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0013125', 'thorax swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333080, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0031273', 'decreased susceptibility to induced aneurysm formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333081, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.43478260869565216, 4.8755453832354885, 1.4559540997356917, 'UPHENO:0086172', 'abnormal cell'),
(333082, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0002113', 'abnormal skeleton development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333083, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0013120', 'urogenital swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333084, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0020982', 'abnormal skin adnexa development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333085, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0010233', 'hairless tail', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333086, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333087, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0000733', 'abnormal muscle development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333088, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0031310', 'abnormal cyst', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333089, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0005029', 'abnormal amnion morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333090, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0003077', 'abnormal cell cycle', 0.43478260869565216, 4.8755453832354885, 1.4559540997356917, 'UPHENO:0086172', 'abnormal cell'),
(333091, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0030222', 'hyperostosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333092, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0011203', 'abnormal parietal yolk sac morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333093, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0011167', 'abnormal adipose tissue development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333094, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0031377', 'ambiguous external genitalia', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333095, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.4166666666666667, 4.8755453832354885, 1.4252990012677296, 'UPHENO:0086172', 'abnormal cell'),
(333096, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0005076', 'abnormal cell differentiation', 0.43478260869565216, 4.8755453832354885, 1.4559540997356917, 'UPHENO:0086172', 'abnormal cell'),
(333097, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0020846', 'abnormal cell motility', 0.43478260869565216, 4.8755453832354885, 1.4559540997356917, 'UPHENO:0086172', 'abnormal cell'),
(333098, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333099, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0000462', 'abnormal digestive system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333100, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0008942', 'abnormal induced cell death', 0.4166666666666667, 4.8755453832354885, 1.4252990012677296, 'UPHENO:0086172', 'abnormal cell'),
(333101, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0003091', 'abnormal cell migration', 0.4166666666666667, 4.8755453832354885, 1.4252990012677296, 'UPHENO:0086172', 'abnormal cell'),
(333102, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0002160', 'abnormal reproductive system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333103, 'HP:0031551', 'Reduced cell surface marker level', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333104, 'HP:0034811', 'Bent sperm flagella', 'MP:0001124', 'abnormal gametes', 0.4186046511627907, 10.791230332350247, 2.1253844849557932, 'UPHENO:0085194', 'abnormal gamete'),
(333105, 'HP:0034811', 'Bent sperm flagella', 'MP:0020550', 'multinucleated giant male germ cells', 0.4090909090909091, 11.607147267911277, 2.179077425834586, 'UPHENO:0084945', 'abnormal male germ cell morphology'),
(333106, 'HP:0034811', 'Bent sperm flagella', 'MP:0005578', 'teratozoospermia', 0.41304347826086957, 11.607147267911277, 2.1895790646204634, 'UPHENO:0084945', 'abnormal male germ cell morphology'),
(333107, 'HP:0034811', 'Bent sperm flagella', 'MP:0006362', 'abnormal male germ cell morphology', 0.4186046511627907, 11.607147267911277, 2.204269909307646, 'UPHENO:0084945', 'abnormal male germ cell morphology'),
(333108, 'HP:0034811', 'Bent sperm flagella', 'MP:0002208', 'abnormal germ cell morphology', 0.40476190476190477, 10.700256672302757, 2.0811189951856535, 'UPHENO:0084966', 'abnormal germ cell morphology'),
(333109, 'HP:0004611', 'Anterior concavity of thoracic vertebrae', 'MP:0004706', 'short vertebral body', 0.40816326530612246, 10.93472192593978, 2.112617288224735, 'UPHENO:0076707', 'abnormal bony vertebral centrum morphology'),
(333110, 'HP:0004611', 'Anterior concavity of thoracic vertebrae', 'MP:0000137', 'abnormal vertebrae morphology', 0.43243243243243246, 8.941811350726098, 1.9664000693517127, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(333111, 'HP:0004611', 'Anterior concavity of thoracic vertebrae', 'MP:0021136', 'abnormal vertebrae shape', 0.4418604651162791, 8.941811350726098, 1.9877205342838962, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(333112, 'HP:0004611', 'Anterior concavity of thoracic vertebrae', 'MP:0004704', 'short vertebral column', 0.4090909090909091, 8.557298718460714, 1.8710192709049165, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(333113, 'HP:0004611', 'Anterior concavity of thoracic vertebrae', 'MP:0005227', 'abnormal vertebral body development', 0.4146341463414634, 10.93472192593978, 2.129297792992639, 'UPHENO:0076707', 'abnormal bony vertebral centrum morphology'),
(333114, 'HP:0004611', 'Anterior concavity of thoracic vertebrae', 'MP:0013612', 'enlarged caudal vertebrae', 0.40425531914893614, 8.941811350726098, 1.9012561114582536, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(333115, 'HP:0004611', 'Anterior concavity of thoracic vertebrae', 'MP:0004669', 'enlarged vertebral body', 0.46511627906976744, 10.93472192593978, 2.255197812799514, 'UPHENO:0076707', 'abnormal bony vertebral centrum morphology'),
(333116, 'HP:0004611', 'Anterior concavity of thoracic vertebrae', 'MP:0004687', 'split vertebrae', 0.40425531914893614, 8.941811350726098, 1.9012561114582536, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(333117, 'HP:0004611', 'Anterior concavity of thoracic vertebrae', 'MP:0004626', 'vertebral compression', 0.4222222222222222, 8.941811350726098, 1.943046952390874, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(333118, 'HP:0004611', 'Anterior concavity of thoracic vertebrae', 'MP:0004657', 'small sacral vertebrae', 0.41304347826086957, 8.941811350726098, 1.9218108289466038, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(333119, 'HP:0004611', 'Anterior concavity of thoracic vertebrae', 'MP:0008832', 'hemivertebra', 0.42105263157894735, 8.941811350726098, 1.9403538853275515, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(333120, 'HP:0004611', 'Anterior concavity of thoracic vertebrae', 'MP:0031313', 'spondylolisthesis', 0.40540540540540543, 8.557298718460714, 1.86257218816687, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(333121, 'HP:0004611', 'Anterior concavity of thoracic vertebrae', 'MP:0008771', 'elongated vertebral column', 0.4090909090909091, 8.557298718460714, 1.8710192709049165, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(333122, 'HP:0004611', 'Anterior concavity of thoracic vertebrae', 'MP:0004705', 'elongated vertebral body', 0.4166666666666667, 10.93472192593978, 2.134510280089614, 'UPHENO:0076707', 'abnormal bony vertebral centrum morphology'),
(333123, 'HP:0004611', 'Anterior concavity of thoracic vertebrae', 'MP:0003050', 'abnormal sacral vertebrae morphology', 0.41025641025641024, 8.941811350726098, 1.9153160120301067, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(333124, 'HP:0004611', 'Anterior concavity of thoracic vertebrae', 'MP:0003049', 'abnormal lumbar vertebrae morphology', 0.40476190476190477, 8.941811350726098, 1.902447001716872, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(333125, 'HP:0004611', 'Anterior concavity of thoracic vertebrae', 'MP:0013972', 'occipital vertebra', 0.42105263157894735, 8.941811350726098, 1.9403538853275515, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(333126, 'HP:0004611', 'Anterior concavity of thoracic vertebrae', 'MP:0004600', 'abnormal vertebral transverse process morphology', 0.40476190476190477, 8.941811350726098, 1.902447001716872, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(333127, 'HP:0004611', 'Anterior concavity of thoracic vertebrae', 'MP:0004703', 'abnormal vertebral column morphology', 0.4166666666666667, 8.557298718460714, 1.8882640526928336, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(333128, 'HP:0004611', 'Anterior concavity of thoracic vertebrae', 'MP:0004643', 'abnormal vertebrae number', 0.4146341463414634, 8.941811350726098, 1.9255078073471226, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(333129, 'HP:0004611', 'Anterior concavity of thoracic vertebrae', 'MP:0021137', 'abnormal wedge-shaped vertebrae', 0.4318181818181818, 8.941811350726098, 1.9650029820923236, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(333130, 'HP:0004611', 'Anterior concavity of thoracic vertebrae', 'MP:0004602', 'abnormal vertebral articular process morphology', 0.40476190476190477, 8.941811350726098, 1.902447001716872, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(333131, 'HP:0004611', 'Anterior concavity of thoracic vertebrae', 'MP:0004610', 'small vertebrae', 0.4523809523809524, 8.941811350726098, 2.011244673045098, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(333132, 'HP:0004611', 'Anterior concavity of thoracic vertebrae', 'MP:0004174', 'abnormal spine curvature', 0.40540540540540543, 8.557298718460714, 1.86257218816687, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(333133, 'HP:0004611', 'Anterior concavity of thoracic vertebrae', 'MP:0004707', 'enlarged lumbar vertebrae', 0.40425531914893614, 8.941811350726098, 1.9012561114582536, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(333134, 'HP:0004611', 'Anterior concavity of thoracic vertebrae', 'MP:0000459', 'abnormal presacral vertebrae morphology', 0.4358974358974359, 8.941811350726098, 1.974262556009229, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(333135, 'HP:0004611', 'Anterior concavity of thoracic vertebrae', 'MP:0003036', 'vertebral transformation', 0.42105263157894735, 8.941811350726098, 1.9403538853275515, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(333136, 'HP:0004611', 'Anterior concavity of thoracic vertebrae', 'MP:0000141', 'abnormal vertebral body morphology', 0.4473684210526316, 10.93472192593978, 2.2117525364871335, 'UPHENO:0076707', 'abnormal bony vertebral centrum morphology'),
(333137, 'HP:0004611', 'Anterior concavity of thoracic vertebrae', 'MP:0005225', 'abnormal vertebrae development', 0.41025641025641024, 8.941811350726098, 1.9153160120301067, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(333138, 'HP:0004611', 'Anterior concavity of thoracic vertebrae', 'MP:0004670', 'small vertebral body', 0.45454545454545453, 10.93472192593978, 2.22942327702804, 'UPHENO:0076707', 'abnormal bony vertebral centrum morphology'),
(333139, 'HP:0004611', 'Anterior concavity of thoracic vertebrae', 'MP:0031312', 'spondylolysis', 0.40540540540540543, 8.557298718460714, 1.86257218816687, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(333140, 'HP:0004374', 'Hemiplegia/hemiparesis', 'MP:0009967', 'abnormal neuron proliferation', 0.4358974358974359, 11.437222266468964, 2.23281344042508, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(333141, 'HP:0004374', 'Hemiplegia/hemiparesis', 'MP:0004768', 'abnormal axonal transport', 0.4473684210526316, 11.437222266468964, 2.2620017830625647, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(333142, 'HP:0004374', 'Hemiplegia/hemiparesis', 'MP:0021001', 'impaired neuron physiology', 0.4473684210526316, 11.437222266468964, 2.2620017830625647, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(333143, 'HP:0004374', 'Hemiplegia/hemiparesis', 'MP:0003202', 'abnormal neuron apoptosis', 0.425, 11.437222266468964, 2.2047266187101995, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(333144, 'HP:0004374', 'Hemiplegia/hemiparesis', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.4473684210526316, 11.437222266468964, 2.2620017830625647, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(333145, 'HP:0004374', 'Hemiplegia/hemiparesis', 'MP:0004811', 'abnormal neuron physiology', 0.4594594594594595, 11.437222266468964, 2.2923655817232826, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(333146, 'HP:0004374', 'Hemiplegia/hemiparesis', 'MP:0010653', 'abnormal Wallerian degeneration', 0.425, 11.437222266468964, 2.2047266187101995, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(333147, 'HP:0004374', 'Hemiplegia/hemiparesis', 'MP:0005621', 'abnormal cell physiology', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(333148, 'HP:0004374', 'Hemiplegia/hemiparesis', 'MP:0003633', 'abnormal nervous system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(333149, 'HP:0004374', 'Hemiplegia/hemiparesis', 'MP:0010654', 'slow Wallerian degeneration', 0.4146341463414634, 11.437222266468964, 2.177673733821239, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(333150, 'HP:0004374', 'Hemiplegia/hemiparesis', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.4473684210526316, 11.437222266468964, 2.2620017830625647, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(333151, 'HP:0034546', 'Presence of uterus in 46,XY individual', 'MP:0002210', 'abnormal sex determination', 0.41379310344827586, 7.392828147110509, 1.749028673936658, 'UPHENO:0087547', 'abnormal reproductive system morphology'),
(333152, 'HP:0034546', 'Presence of uterus in 46,XY individual', 'MP:0031377', 'ambiguous external genitalia', 0.41379310344827586, 7.392828147110509, 1.749028673936658, 'UPHENO:0087547', 'abnormal reproductive system morphology'),
(333153, 'HP:0034546', 'Presence of uterus in 46,XY individual', 'MP:0001929', 'abnormal gametogenesis', 0.41379310344827586, 7.392828147110509, 1.749028673936658, 'UPHENO:0087547', 'abnormal reproductive system morphology'),
(333154, 'HP:0034546', 'Presence of uterus in 46,XY individual', 'MP:0002582', 'disorganized extraembryonic tissue', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(333155, 'HP:0034546', 'Presence of uterus in 46,XY individual', 'MP:0001116', 'small gonad', 0.42857142857142855, 7.392828147110509, 1.7799873370870418, 'UPHENO:0087547', 'abnormal reproductive system morphology'),
(333156, 'HP:0034546', 'Presence of uterus in 46,XY individual', 'MP:0003936', 'abnormal reproductive system development', 0.41379310344827586, 7.392828147110509, 1.749028673936658, 'UPHENO:0087547', 'abnormal reproductive system morphology'),
(333157, 'HP:0034546', 'Presence of uterus in 46,XY individual', 'MP:0031094', 'organomegaly', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(333158, 'HP:0034546', 'Presence of uterus in 46,XY individual', 'MP:0002160', 'abnormal reproductive system morphology', 0.42857142857142855, 7.392828147110509, 1.7799873370870418, 'UPHENO:0087547', 'abnormal reproductive system morphology'),
(333159, 'HP:0034546', 'Presence of uterus in 46,XY individual', 'MP:0003956', 'abnormal body size', 0.41935483870967744, 3.067140347159989, 1.134116460326373, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(333160, 'HP:0032435', 'Neonatal omphalitis', 'MP:0002163', 'abnormal gland morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333161, 'HP:0032435', 'Neonatal omphalitis', 'MP:0014134', 'abnormal embryo morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333162, 'HP:0032435', 'Neonatal omphalitis', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333163, 'HP:0032435', 'Neonatal omphalitis', 'MP:0005500', 'abnormal gustatory system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333164, 'HP:0032435', 'Neonatal omphalitis', 'MP:0002111', 'abnormal tail morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333165, 'HP:0032435', 'Neonatal omphalitis', 'MP:0010678', 'abnormal skin adnexa morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333166, 'HP:0032435', 'Neonatal omphalitis', 'MP:0005499', 'abnormal olfactory system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333167, 'HP:0032435', 'Neonatal omphalitis', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333168, 'HP:0032435', 'Neonatal omphalitis', 'MP:0001725', 'abnormal umbilical cord morphology', 0.4166666666666667, 12.192109768632433, 2.2538956801347707, 'UPHENO:0075872', 'abnormal umbilical cord'),
(333169, 'HP:0032435', 'Neonatal omphalitis', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333170, 'HP:0032435', 'Neonatal omphalitis', 'MP:0003385', 'abnormal body wall morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333171, 'HP:0200046', 'Cat cry', 'MP:0013332', 'peliosis', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333172, 'HP:0200046', 'Cat cry', 'MP:0002160', 'abnormal reproductive system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333173, 'HP:0200046', 'Cat cry', 'MP:0000266', 'abnormal heart morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333174, 'HP:0200046', 'Cat cry', 'MP:0005457', 'abnormal percent body fat/body weight', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333175, 'HP:0200046', 'Cat cry', 'MP:0010233', 'hairless tail', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333176, 'HP:0200046', 'Cat cry', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333177, 'HP:0200046', 'Cat cry', 'MP:0005029', 'abnormal amnion morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333178, 'HP:0200046', 'Cat cry', 'MP:0010680', 'abnormal skin adnexa physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333179, 'HP:0200046', 'Cat cry', 'MP:0002925', 'abnormal cardiovascular development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333180, 'HP:0200046', 'Cat cry', 'MP:0001985', 'abnormal gustatory system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333181, 'HP:0200046', 'Cat cry', 'MP:0013113', 'greasy tail', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333182, 'HP:0200046', 'Cat cry', 'MP:0005499', 'abnormal olfactory system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333183, 'HP:0200046', 'Cat cry', 'MP:0003115', 'abnormal respiratory system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333184, 'HP:0200046', 'Cat cry', 'MP:0013558', 'abnormal exocrine gland morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333185, 'HP:0200046', 'Cat cry', 'MP:0004134', 'abnormal chest morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333186, 'HP:0200046', 'Cat cry', 'MP:0010478', 'intracranial aneurysm', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333187, 'HP:0200046', 'Cat cry', 'MP:0003890', 'abnormal embryonic-extraembryonic boundary morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333188, 'HP:0200046', 'Cat cry', 'MP:0010678', 'abnormal skin adnexa morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333189, 'HP:0200046', 'Cat cry', 'MP:0000733', 'abnormal muscle development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333190, 'HP:0200046', 'Cat cry', 'MP:0003385', 'abnormal body wall morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333191, 'HP:0200046', 'Cat cry', 'MP:0013126', 'teat swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333192, 'HP:0200046', 'Cat cry', 'MP:0000685', 'abnormal immune system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333193, 'HP:0200046', 'Cat cry', 'MP:0010126', 'abnormal distal visceral endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333194, 'HP:0200046', 'Cat cry', 'MP:0012260', 'encephalomeningocele', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333195, 'HP:0200046', 'Cat cry', 'MP:0013121', 'testicular swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333196, 'HP:0200046', 'Cat cry', 'MP:0000003', 'abnormal adipose tissue morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333197, 'HP:0200046', 'Cat cry', 'MP:0003936', 'abnormal reproductive system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333198, 'HP:0200046', 'Cat cry', 'MP:0012500', 'abnormal angioblastic cord morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333199, 'HP:0200046', 'Cat cry', 'MP:0003279', 'aneurysm', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333200, 'HP:0200046', 'Cat cry', 'MP:0005508', 'abnormal skeleton morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333201, 'HP:0200046', 'Cat cry', 'MP:0002163', 'abnormal gland morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333202, 'HP:0200046', 'Cat cry', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333203, 'HP:0200046', 'Cat cry', 'MP:0001718', 'abnormal visceral yolk sac morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333204, 'HP:0200046', 'Cat cry', 'MP:0013119', 'abdomen swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333205, 'HP:0200046', 'Cat cry', 'MP:0013125', 'thorax swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333206, 'HP:0200046', 'Cat cry', 'MP:0010736', 'abnormal extraembryonic ectoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333207, 'HP:0200046', 'Cat cry', 'MP:0003861', 'abnormal nervous system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333208, 'HP:0200046', 'Cat cry', 'MP:0000752', 'dystrophic muscle', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333209, 'HP:0200046', 'Cat cry', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333210, 'HP:0200046', 'Cat cry', 'MP:0003935', 'abnormal craniofacial development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333211, 'HP:0200046', 'Cat cry', 'MP:0020973', 'abnormal gland development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333212, 'HP:0200046', 'Cat cry', 'MP:0001929', 'abnormal gametogenesis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333213, 'HP:0200046', 'Cat cry', 'MP:0011174', 'lipodystrophy', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333214, 'HP:0200046', 'Cat cry', 'MP:0008923', 'thoracoschisis', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333215, 'HP:0200046', 'Cat cry', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333216, 'HP:0200046', 'Cat cry', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333217, 'HP:0200046', 'Cat cry', 'MP:0031099', 'abnormal sputum morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333218, 'HP:0200046', 'Cat cry', 'MP:0002113', 'abnormal skeleton development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333219, 'HP:0200046', 'Cat cry', 'MP:0003942', 'abnormal urinary system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333220, 'HP:0200046', 'Cat cry', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333221, 'HP:0200046', 'Cat cry', 'MP:0013283', 'failure of ventral body wall closure', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333222, 'HP:0200046', 'Cat cry', 'MP:0031310', 'abnormal cyst', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333223, 'HP:0200046', 'Cat cry', 'MP:0013122', 'tail swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333224, 'HP:0200046', 'Cat cry', 'MP:0011203', 'abnormal parietal yolk sac morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333225, 'HP:0200046', 'Cat cry', 'MP:0008533', 'abnormal anterior visceral endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333226, 'HP:0200046', 'Cat cry', 'MP:0012514', 'pectus excavatum', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333227, 'HP:0200046', 'Cat cry', 'MP:0030222', 'hyperostosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333228, 'HP:0200046', 'Cat cry', 'MP:0011200', 'abnormal extraembryonic coelom morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333229, 'HP:0200046', 'Cat cry', 'MP:0002085', 'abnormal embryonic tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333230, 'HP:0200046', 'Cat cry', 'MP:0002108', 'abnormal muscle morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333231, 'HP:0200046', 'Cat cry', 'MP:0011167', 'abnormal adipose tissue development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333232, 'HP:0200046', 'Cat cry', 'MP:0013118', 'swellings', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333233, 'HP:0200046', 'Cat cry', 'MP:0011199', 'abnormal amniotic cavity morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333234, 'HP:0200046', 'Cat cry', 'MP:0002132', 'abnormal respiratory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333235, 'HP:0200046', 'Cat cry', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333236, 'HP:0200046', 'Cat cry', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333237, 'HP:0200046', 'Cat cry', 'MP:0030572', 'abnormal pilosebaceous unit morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333238, 'HP:0200046', 'Cat cry', 'MP:0010352', 'gastrointestinal tract polyps', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333239, 'HP:0200046', 'Cat cry', 'MP:0003119', 'abnormal digestive system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333240, 'HP:0200046', 'Cat cry', 'MP:0002109', 'abnormal limb morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333241, 'HP:0200046', 'Cat cry', 'MP:0031273', 'decreased susceptibility to induced aneurysm formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333242, 'HP:0200046', 'Cat cry', 'MP:0013177', 'abnormal tail tip morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333243, 'HP:0200046', 'Cat cry', 'MP:0031377', 'ambiguous external genitalia', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333244, 'HP:0200046', 'Cat cry', 'MP:0000428', 'abnormal craniofacial morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333245, 'HP:0200046', 'Cat cry', 'MP:0002164', 'abnormal gland physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333246, 'HP:0200046', 'Cat cry', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333247, 'HP:0200046', 'Cat cry', 'MP:0020982', 'abnormal skin adnexa development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333248, 'HP:0200046', 'Cat cry', 'MP:0003632', 'abnormal nervous system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333249, 'HP:0200046', 'Cat cry', 'MP:0013120', 'urogenital swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333250, 'HP:0200046', 'Cat cry', 'MP:0006281', 'abnormal tail development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333251, 'HP:0200046', 'Cat cry', 'MP:0001726', 'abnormal allantois morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333252, 'HP:0200046', 'Cat cry', 'MP:0005500', 'abnormal gustatory system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333253, 'HP:0200046', 'Cat cry', 'MP:0002836', 'abnormal chorion morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333254, 'HP:0200046', 'Cat cry', 'MP:0014134', 'abnormal embryo morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333255, 'HP:0200046', 'Cat cry', 'MP:0001983', 'abnormal olfactory system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333256, 'HP:0200046', 'Cat cry', 'MP:0002210', 'abnormal sex determination', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333257, 'HP:0200046', 'Cat cry', 'MP:0005360', 'urolithiasis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333258, 'HP:0200046', 'Cat cry', 'MP:0014062', 'nervous system inclusion bodies', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333259, 'HP:0200046', 'Cat cry', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333260, 'HP:0200046', 'Cat cry', 'MP:0013133', 'pale limbs', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333261, 'HP:0200046', 'Cat cry', 'MP:0003795', 'abnormal bone structure', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333262, 'HP:0200046', 'Cat cry', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333263, 'HP:0200046', 'Cat cry', 'MP:0000462', 'abnormal digestive system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333264, 'HP:0200046', 'Cat cry', 'MP:0013123', 'head/neck swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333265, 'HP:0200046', 'Cat cry', 'MP:0031274', 'increased susceptibility to induced aneurysm formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333266, 'HP:0200046', 'Cat cry', 'MP:0031277', 'pectus carinatum', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333267, 'HP:0200046', 'Cat cry', 'MP:0006279', 'abnormal limb development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333268, 'HP:0200046', 'Cat cry', 'MP:0002111', 'abnormal tail morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333269, 'HP:0200046', 'Cat cry', 'MP:0003300', 'gastrointestinal ulcer', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333270, 'HP:0200046', 'Cat cry', 'MP:0020981', 'abnormal immune system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333271, 'HP:0200046', 'Cat cry', 'MP:0013124', 'mouth swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333272, 'HP:0200046', 'Cat cry', 'MP:0003384', 'abnormal ventral body wall morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(333273, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333274, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333275, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333276, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333277, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333278, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333279, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333280, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333281, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0012565', 'perivasculitis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333282, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333283, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333284, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333285, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333286, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0009792', 'seborrheic dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333287, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333288, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333289, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333290, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333291, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333292, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333293, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333294, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333295, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333296, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333297, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333298, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333299, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333300, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333301, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333302, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333303, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333304, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333305, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333306, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0031066', 'cytokine storm', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333307, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333308, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333309, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333310, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0013459', 'perioral dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333311, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333312, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333313, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333314, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333315, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333316, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333317, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333318, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333319, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333320, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333321, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333322, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333323, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333324, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333325, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333326, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333327, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333328, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333329, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333330, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333331, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333332, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333333, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333334, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0003777', 'lip inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333335, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333336, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333337, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333338, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333339, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333340, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333341, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333342, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333343, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333344, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333345, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333346, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0003454', 'erythroderma', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333347, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333348, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333349, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333350, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333351, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333352, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333353, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333354, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333355, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333356, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333357, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333358, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333359, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333360, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333361, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333362, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333363, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333364, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333365, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333366, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333367, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333368, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333369, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333370, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333371, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333372, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333373, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333374, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333375, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333376, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333377, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333378, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333379, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333380, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333381, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333382, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333383, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333384, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333385, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333386, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333387, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333388, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333389, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333390, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333391, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333392, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333393, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333394, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333395, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333396, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333397, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333398, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333399, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333400, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333401, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333402, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333403, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333404, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333405, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333406, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333407, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333408, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333409, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333410, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333411, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333412, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333413, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333414, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333415, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333416, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333417, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333418, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333419, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333420, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333421, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0031095', 'pharyngitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333422, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333423, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333424, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333425, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0003767', 'palate inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333426, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333427, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333428, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0030130', 'gum inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333429, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333430, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333431, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333432, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333433, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333434, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333435, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333436, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333437, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333438, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333439, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333440, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333441, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333442, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333443, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333444, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333445, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333446, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333447, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333448, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333449, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333450, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333451, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333452, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333453, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0031051', 'lymph node hemorrhage', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333454, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333455, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333456, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0010922', 'alveolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333457, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333458, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0003471', 'abnormal summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333459, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333460, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333461, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333462, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333463, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333464, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333465, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333466, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333467, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333468, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0031110', 'meningitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333469, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333470, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333471, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333472, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333473, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333474, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333475, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333476, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333477, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333478, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333479, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333480, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333481, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333482, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333483, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333484, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333485, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333486, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333487, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333488, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333489, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333490, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333491, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333492, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0031055', 'bronchitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333493, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333494, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333495, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333496, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333497, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333498, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333499, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333500, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333501, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333502, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333503, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333504, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333505, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333506, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333507, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333508, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333509, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333510, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333511, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333512, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333513, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333514, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333515, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333516, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333517, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333518, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0005044', 'sepsis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333519, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333520, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333521, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333522, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333523, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333524, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333525, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333526, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333527, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333528, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0011763', 'urethritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333529, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333530, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333531, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333532, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333533, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333534, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333535, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333536, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333537, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333538, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333539, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333540, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333541, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333542, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333543, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333544, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333545, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333546, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333547, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333548, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333549, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333550, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333551, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333552, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333553, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333554, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333555, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333556, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333557, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333558, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333559, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333560, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333561, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333562, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333563, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333564, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333565, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333566, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333567, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333568, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333569, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333570, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333571, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0013942', 'enthesitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333572, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333573, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333574, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333575, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333576, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333577, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333578, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333579, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333580, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333581, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333582, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333583, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333584, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333585, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333586, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333587, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333588, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0031242', 'increased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333589, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333590, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333591, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333592, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333593, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0031241', 'decreased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333594, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333595, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333596, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333597, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333598, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333599, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333600, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333601, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333602, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333603, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333604, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333605, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333606, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333607, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333608, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333609, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333610, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0010539', 'decreased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333611, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333612, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333613, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333614, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333615, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333616, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333617, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333618, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333619, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0021015', 'increased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333620, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333621, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333622, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333623, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333624, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333625, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333626, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333627, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333628, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(333629, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333630, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(333631, 'HP:0031907', 'Anti-mitochondrial M2 antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
